Date,Title,Link,Status,Source
"""17 hours ago""","""Revenue Approximations Analysis: Urban Outfitters, Inc. (URBN), Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsjournal.com/2017/11/29/revenue-approximations-analysis-urban-outfitters-inc-urbn-amgen-inc-amgn/&cid=52779696117756&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEteumdkKdcqtZVMJEoScRmidhc6g""",1,"""StockNewsJournal"""
"""Nov 15, 2017""","""Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 16,\u00a02017""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/amgen-inc-amgn-ex-dividend-date-scheduled-for-november-16-2017-cm877656&cid=52779675738818&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNFH-9d9s-mSAOiSL71ZAU_IoXYykQ""",2,"""Nasdaq"""
"""Nov 29, 2017""","""Amgen Inc. (NASDAQ:AMGN) Stake Raised by Pacer Advisors\u00a0Inc.""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/29/pacer-advisors-inc-has-4-37-million-stake-in-amgen-inc-amgn.html&cid=52779691929472&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHn7XzpjWraze31JUAe1gNAnS4yQQ""",Not Reachable,"""The Ledger Gazette"""
"""Nov 28, 2017""","""Why Investors remained buoyant on: Amgen Inc. (AMGN), Twenty-First Century Fox\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/28/why-investors-remained-buoyant-on-amgen-inc-amgn-twenty-first-century-fox-inc-fox/&cid=52779691131238&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNGajnFGnHY5ero-JlVbez1O8qS-YA""",3,"""StockNewsJournal"""
"""Nov 2, 2017""","""Halbert, Hargrove Buys Apple Inc, DowDuPont Inc, Amgen Inc, Sells PIMCO\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/halbert-hargrove-buys-apple-inc-dowdupont-inc-amgen-inc-sells-pimco-enhanced-short-maturity-cm871079&cid=0&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEi0lG0zWVOCkIs5FM6Ag-fo2APGA""",4,"""Nasdaq"""
"""Nov 27, 2017""","""Today Analysts Focus on DiamondRock Hospitality Company (DRH), Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/27/today-analysts-focus-on-diamondrock-hospitality-company-drh-amgen-inc-amgn/&cid=52779689380474&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEXjZ6wcoRRFVlSc_ryc2b7vSuErQ""",5,"""StockNewsJournal"""
"""13 hours ago""","""Now Is The Time To Reconsider Amgen Inc. (AMGN), International Business\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.allstocknews.com/2017/11/29/now-is-the-time-to-reconsider-amgen-inc-amgn-international-business-machines-corporation-ibm/&cid=52779693083344&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHRIYhh04a-WjNSrlGSfKCzAsFe7A""",6,"""AllStockNews"""
"""Nov 11, 2017""","""Amgen will lay off about 200 people, including some in Thousand\u00a0Oaks""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.vcstar.com/story/money/business/2017/11/10/amgen-layoff-200-people-california-including-some-thousand-oaks/852937001/&cid=0&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNGLQGHbmk99c2SsLXUfgy1-A4OHhA""",7,"""Ventura County Star"""
"""Nov 27, 2017""","""Dissecting the Investment Cases for Editas Medicine, Inc. (EDIT) and Amgen Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://economicsandmoney.com/2017/11/27/dissecting-the-investment-cases-for-editas-medicine-inc-edit-and-amgen-inc-amgn/&cid=52779689209014&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNFaSvvmUbMfqsffmET0tAhsgaCAvw""",8,"""Economic News"""
"""14 hours ago""","""Are These Going Behind the Curtain? Amgen Inc. (AMGN), Lam Research\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://financialqz.com/2017/11/29/are-these-going-behind-the-curtain-amgen-inc-amgn-lam-research-corporation-lrcx/&cid=52779696171553&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEtKGC4Bh_MUSUUyDg5FROmewLVkw""",9,"""Market Movers"""
"""Nov 14, 2017""","""Amgen is\u00a0Oversold""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/amgen-is-oversold-cm877183&cid=52779676393164&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHnpUt4coWTuBzHBXvKyuHrezv-0A""",10,"""Nasdaq"""
"""Oct 31, 2017""","""Japan's Kirin cashes out of Amgen drug joint\u00a0venture""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.reuters.com/article/us-amgen-kirin-m-a/japans-kirin-cashes-out-of-amgen-drug-joint-venture-idUSKBN1D00YP&cid=52779657273570&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNFTmQQWUwyul5ZNiSjxQ4xyR7ocKQ""",11,"""Reuters"""
"""Nov 24, 2017""","""Analytical Guide for two rising stock's: Hologic, Inc. (HOLX), Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/24/analytical-guide-for-two-rising-stocks-hologic-inc-holx-amgen-inc-amgn/&cid=52779687026479&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNH6RoRhxjwjSuPGqGOcdOX6Nmr-pg""",12,"""StockNewsJournal"""
"""4 hours ago""","""Amgen Inc. (NASDAQ:AMGN) Shares Sold by Zurcher Kantonalbank Zurich\u00a0Cantonalbank""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.truebluetribune.com/2017/11/30/amgen-inc-amgn-position-lessened-by-zurcher-kantonalbank-zurich-cantonalbank.html&cid=52779697183210&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNE1TUN1AaKsnwJJ8OgNoVGXYOIh9Q""",Not Reachable,"""TrueBlueTribune"""
"""Nov 24, 2017""","""River Road Asset Management LLC Decreases Position in Amgen Inc.\u00a0(NASDAQ:AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/24/amgen-inc-amgn-shares-sold-by-river-road-asset-management-llc.html&cid=52779687454545&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNFbnM87dTdpO1qUuflQ7P7Rt9EN4Q""",Not Reachable,"""The Ledger Gazette"""
"""16 hours ago""","""Between The Numbers: Akamai Technologies, Inc. (AKAM), Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://usacommercedaily.com/2017/11/29/between-the-numbers-akamai-technologies-inc-akam-amgen-inc-amgn/&cid=52779695809597&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNE-v9eIeM5JreMVzGkuHb0WW4AK_Q""",13,"""USA Commerce Daily"""
"""Nov 28, 2017""","""Reflections On The Current State Of Marathon Petroleum Corporation (MPC\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.allstocknews.com/2017/11/28/reflections-on-the-current-state-of-marathon-petroleum-corporation-mpc-amgen-inc-amgn/&cid=52779692150887&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHD5pJJ70sRNX6ZZq4H_sLstIzpoQ""",14,"""AllStockNews"""
"""15 hours ago""","""Company Spotlight on Shares of Amgen Inc.\u00a0(NasdaqGS:AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://finnewsweek.com/company-spotlight-on-shares-of-amgen-inc-nasdaqgsamgn/561333/&cid=52779696485382&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNGitWO5oCqGRyc172KX9mlJV8sFag""",15,"""Financial Newsweek"""
"""Nov 20, 2017""","""Analysts think these stock's can be a game changer: Amgen Inc. (AMGN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsjournal.com/2017/11/20/analysts-think-these-stocks-can-be-a-game-changer-amgen-inc-amgn-washington-prime-group-inc-wpg/&cid=52779678499794&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNG9xhxiBQhrdtHgMQjrlRTWOLuQdg""",16,"""StockNewsJournal"""
"""13 hours ago""","""Bullish Two Hundred Day Moving Average Cross -\u00a0AMGN""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/bullish-two-hundred-day-moving-average-cross-amgn-cm884036&cid=52779696547497&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHFhW-QZI4-Dsp4e4H26e9UW87JKQ""",17,"""Nasdaq"""
"""Nov 22, 2017""","""Is It Time to go for JetBlue Airways Corporation (JBLU), Amgen Inc.\u00a0(AMGN)?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsjournal.com/2017/11/22/is-it-time-to-go-for-jetblue-airways-corporation-jblu-amgen-inc-amgn/&cid=52779679780324&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNGowInvZ7vGyIkSpgRGY-83IeAA0g""",18,"""StockNewsJournal"""
"""17 hours ago""","""Charming Stocks: Amgen Inc., (NASDAQ: AMGN), ReWalk Robotics Ltd., (NASDAQ\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/29/charming-stocks-amgen-inc-nasdaq-amgn-rewalk-robotics-ltd-nasdaq-rwlk-tal-education-group-nyse-tal-kimberly-clark-corporation-nyse-kmb/&cid=52779693158489&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHyhgzTCEOcZYqoXpoxl3z1qNg-Xg""",19,"""Stocks In The News (press release)"""
"""11 hours ago""","""Technical Secrets: Amgen Inc (NASDAQ:\u00a0AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://alphabetastock.com/technical-secrets-amgen-inc-nasdaq-amgn/&cid=52779695716913&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEsfHU97kV4mP2Aut2cjfmxMZsymg""",20,"""Alpha Beta Stock"""
"""20 hours ago""","""Trump's Tax Promises Undercut by CEO Plans to Help\u00a0Investors""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.bloomberg.com/news/articles/2017-11-29/trump-s-tax-promises-undercut-by-ceo-plans-to-reward-investors&cid=52779696858928&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNH1oipw43S7DxQZe8EivUU4skMAEA""",21,"""Bloomberg"""
"""Nov 22, 2017""","""Utah Retirement Systems Trims Position in Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/22/utah-retirement-systems-sells-3000-shares-of-amgen-inc-amgn-2.html&cid=52779683677674&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEOZy5r3e9H0j7tcoGRv_gJQKiF5Q""",Not Reachable,"""The Ledger Gazette"""
"""Nov 28, 2017""","""Major Analyst Actions Under Review: Baxter International Inc. (BAX), Amgen Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/28/major-analyst-actions-under-review-baxter-international-inc-bax-amgen-inc-amgn/&cid=52779694807768&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNFBrIJ-CUqIhEKF8pu01jocJ6ekUA""",22,"""Post Analyst"""
"""13 hours ago""","""Retail Shareholders Should Not Ignore Historical Volatility \u2013 Amgen Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://stocksnewstimes.com/2017/11/29/retail-shareholders-should-not-ignore-historical-volatility-amgen-inc-nasdaq-amgn/&cid=52779696541435&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNFC4hkIRO78QZQrUOzjte1ddb2Baw""",23,"""Stock Watch"""
"""Nov 6, 2017""","""Buy or Sell? What Analysts Recommends: Amgen Inc. (AMGN), Weyerhaeuser Company\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/06/buy-or-sell-what-analysts-recommends-amgen-inc-amgn-weyerhaeuser-company-wy/&cid=52779664592255&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNGpoBVbsuLYgzQ9NiueOLUjkQt89A""",24,"""StockNewsJournal"""
"""Nov 13, 2017""","""Is It Time to go for Fastenal Company (FAST), Amgen Inc.\u00a0(AMGN)?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/13/is-it-time-to-go-for-fastenal-company-fast-amgen-inc-amgn/&cid=52779672317642&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEqgmMwMeCgfkYqzgqqoP7zYRdvkQ""",25,"""StockNewsJournal"""
"""Nov 24, 2017""","""Analyzing Stocks On Analyst Opinion: Apple Inc. (AAPL), Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/24/analyzing-stocks-on-analyst-opinion-apple-inc-aapl-amgen-inc-amgn/&cid=52779687078009&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEPm8jZWzleQkzjdNiB79bqLA-iXA""",26,"""Post Analyst"""
"""Nov 20, 2017""","""Technical Roundup On Two Stocks \u2013 Amgen Inc. (AMGN), Aimmune Therapeutics, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/20/technical-roundup-on-two-stocks-amgen-inc-amgn-aimmune-therapeutics-inc-aimt/&cid=52779681803187&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHFaxxdt6z8JGwhN-o_lmEtJxRUAg""",27,"""Post Analyst"""
"""Nov 10, 2017""","""Buy or Sell? Average Brokerage Ratings on Amgen Inc. (AMGN), Trevena, Inc.\u00a0(TRVN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsjournal.com/2017/11/10/buy-or-sell-average-brokerage-ratings-on-amgen-inc-amgn-trevena-inc-trvn/&cid=52779670245128&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNFl9dJU6r65mQkG9JsZXCjxcGyO9g""",28,"""StockNewsJournal"""
"""Nov 1, 2017""","""Why Investors remained confident on SunTrust Banks, Inc. (STI), Amgen Inc.\u00a0(AMGN)?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsjournal.com/2017/11/01/why-investors-remained-confident-on-suntrust-banks-inc-sti-amgen-inc-amgn/&cid=52779657630213&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNFM8rV64AUftEEh3ac1hUEK4RLMpQ""",29,"""StockNewsJournal"""
"""Nov 27, 2017""","""Dissecting the Insider Trading Patterns of Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.nystocknews.com/2017/11/27/dissecting-the-insider-trading-patterns-of-amgen-inc-amgn-2/&cid=52779693244498&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNG1VI6SLuMzUGBv-zIgYqlQ2lAvmA""",30,"""NY Stock News"""
"""13 hours ago""","""Market Chatter: Following the Levels for Amgen Inc.\u00a0(NASDAQ:AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://mtnvnews.com/market-chatter-following-the-levels-for-amgen-inc-nasdaqamgn/357492/&cid=52779695468544&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHP0yfkZ5QKnogj4JWHy8Aj9oHtcg""",31,"""MTNV"""
"""Nov 19, 2017""","""Amgen Inc. (AMGN) Receives $190.03 Consensus PT from\u00a0Analysts""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/19/amgen-inc-amgn-receives-190-03-consensus-pt-from-analysts.html&cid=52779679115919&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHNfaKUK0qsOQwrCIwFcTGgdURGrQ""",Not Reachable,"""The Ledger Gazette"""
"""Nov 22, 2017""","""Sizzling Technical Charts: Amgen Inc. (AMGN), Infinity Pharmaceuticals, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/22/sizzling-technical-charts-amgen-inc-amgn-infinity-pharmaceuticals-inc-infi/&cid=52779686636802&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNGHBV5goME8skaPcNwqM8bbHjLKyg""",32,"""Post Analyst"""
"""Nov 26, 2017""","""Stock Alert: Amgen Inc Realized Volatility Hits A Plunging\u00a0Low""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://news.cmlviz.com/2017/11/26/stock-alert-amgen-inc-realized-volatility-hits-a-plunging-low.html&cid=52779692680046&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNEjwHqj5UCh2zK-Bfz5cXOnBgr_2g""",33,"""CML News"""
"""6 hours ago""","""Amgen Inc. (AMG.DE): SuperTrend Above Stock\u00a0Price""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://danvilledaily.com/amgen-inc-amg-de-supertrend-above-stock-price/&cid=52779697450698&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNHD6jRe3kn7BKHd4xm7eMF6wlTzxA""",34,"""Danville Daily"""
"""16 hours ago""","""Are Amgen Inc. (AMG.DE) Shares Brimming\u00a0Over?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://orobulletin.com/are-amgen-inc-amg-de-shares-brimming-over/351823/&cid=52779696303481&ei=3p8fWpDBLpK32AalpZPQDA&usg=AFQjCNGieT2jjwTxcOrLMbqkremb7kHP1w""",35,"""Bulletin News"""
"""Nov 21, 2017""","""Top Stock Picks for the Day: New York REIT, Inc. (NYRT), Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://allstocknews.com/2017/11/21/top-stock-picks-for-the-day-new-york-reit-inc-nyrt-amgen-inc-amgn/&cid=52779686646665&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNHmAbkHg47MrqY2Z3QW8UNkOtK7jA""",36,"""AllStockNews"""
"""Nov 27, 2017""","""Amgen (AMGN) a Hold on Uninspiring Industry Group\u00a0Rank""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://investorplace.com/2017/11/amgen-amgn-a-hold-on-uninspiring-industry-group-rank/&cid=52779693524537&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNF-XBvuiLDotMLr6CZmgFULgrsU1w""",37,"""Investorplace.com"""
"""16 hours ago""","""Are Amgen Inc. (AMG.DE) Shares Brimming\u00a0Over?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://orobulletin.com/are-amgen-inc-amg-de-shares-brimming-over/351823/&cid=52779696303481&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNEdHbbyboSquaqLB4iwzjoQ9dzr1g""",38,"""Bulletin News"""
"""Nov 27, 2017""","""How These 2 Stocks Look on Technical Charts: Amgen Inc. (AMGN), CVS Health\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.postanalyst.com/2017/11/27/how-these-2-stocks-look-on-technical-charts-amgen-inc-amgn-cvs-health-corporation-cvs/&cid=52779692471650&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNHcHtvkIwHGGYUOn-czz2P2TlxPJw""",39,"""Post Analyst"""
"""Nov 14, 2017""","""Ex-Dividend Reminder: US Physical Therapy, Allergan and\u00a0Amgen""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/ex-dividend-reminder-us-physical-therapy-allergan-and-amgen-cm877018&cid=52779668118686&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNGI01-SBmrudM9ye0n9L4A9vi7NOQ""",40,"""Nasdaq"""
"""7 hours ago""","""New Migraine Drugs Show Promise in Race to Sell Next-Generation\u00a0Treatments""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.foxbusiness.com/features/2017/11/29/new-migraine-drugs-show-promise-in-race-to-sell-next-generation-treatments.html&cid=52779696927853&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNED1p2bJ_-Y1nZompHSuaxc3T-Q7A""",41,"""Fox Business"""
"""Nov 20, 2017""","""Earnings Growth Limit Amgen (AMGN)\u00a0Rating""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://investorplace.com/2017/11/earnings-growth-limit-amgen-amgn-rating/&cid=52779684123857&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNHzrf-GqhJviqiLiSr_s5yqfWbT2Q""",42,"""Investorplace.com"""
"""Nov 13, 2017""","""Amgen Gets Positive CHMP Opinion to Expand Nplate's\u00a0Label""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/amgen-gets-positive-chmp-opinion-to-expand-nplates-label-cm876302&cid=52779674249930&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNF3D252mwH-eDykOkmoKqfHoPkSyA""",43,"""Nasdaq"""
"""Nov 28, 2017""","""Is Amgen Inc's (AMGN) 25.96% ROE Good Enough Compared To Its\u00a0Industry?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://simplywall.st/news/2017/11/29/is-amgen-incs-amgn-25-96-roe-good-enough-compared-to-its-industry/&cid=52779694978930&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNH7aarv_YWkTBX2enUsY_uKmY7AZw""",44,"""Simply Wall St"""
"""13 hours ago""","""Technical Focus \u2013 Amgen Inc. (AMGN) stock price comparison to its 20\u00a0SMA""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stocksgallery.com/2017/11/29/technical-focus-amgen-inc-amgn-stock-price-comparison-to-its-20-sma/&cid=52779693379498&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNFYjKQC5k_TYDtmkbTotMloKP6qpg""",45,"""Stocks Gallery"""
"""9 hours ago""","""Amgen Inc. (NASDAQ:AMGN) \u2013 Here's What Day Traders Should\u00a0Know""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://nasdaqjournal.com/index.php/2017/11/29/amgen-inc-nasdaqamgn-heres-what-day-traders-should-know/&cid=52779696379998&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNEovhW6eaI1jz2mDZj-VGUn35NIxw""",46,"""Nasdaq Journal (press release)"""
"""Nov 22, 2017""","""Let's Put These Technical Indicators To Work: Amgen Inc. (AMGN), Hudson\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://allstocknews.com/2017/11/22/lets-put-these-technical-indicators-to-work-amgen-inc-amgn-hudson-pacific-properties-inc-hpp/&cid=52779682638217&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNFRINhV5gAdxu2eVfCtasD-9O8kBA""",47,"""AllStockNews"""
"""Nov 27, 2017""","""Analysts Suggest to Buy Healthcare Stock: Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.streetobserver.com/2017/11/27/analysts-suggest-to-buy-healthcare-stock-amgen-inc-amgn/&cid=52779693631188&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNF53w9DrOztmsdl8B5jDZVDu10m_A""",48,"""Street Observer (press release)"""
"""Nov 24, 2017""","""Hypnotizing Stocks- Amgen Inc. (NASDAQ:AMGN) a Biotechnology\u00a0Company""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.thestreetpoint.com/2017/11/24/hypnotizing-stocks-amgen-inc-nasdaqamgn-a-biotechnology-company/&cid=52779689211764&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNHW6ijPd0woRj7FtxxwKFf1vpHF8w""",49,"""The Stock Street (press release)"""
"""5 hours ago""","""Trump's Deranged Tax Speech Proves He's His Party's Worst\u00a0Salesman""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.vanityfair.com/news/2017/11/trumps-deranged-tax-speech-proves-hes-his-partys-worst-salesman&cid=52779688327954&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNF2FyBarlegJ6ZBxl6JwhlouYRIcw""",50,"""Vanity Fair"""
"""Nov 26, 2017""","""A New Kind of Stock Chart: Amgen Inc (NASDAQ:AMGN) Critical Pivot\u00a0Points""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://news.cmlviz.com/2017/11/26/a-new-kind-of-stock-chart-amgen-inc-nasdaq-amgn--critical-pivot-points.html&cid=52779691890097&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNECfvbaZ8DmvfVkGvRUs2E49yzJgQ""",51,"""CML News"""
"""17 hours ago""","""Analysts Detailing with Profitability Ratio: Amgen Inc. (NASDAQ:AMGN), Sabre\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.investingbizz.com/2017/11/analysts-detailing-with-profitability-ratio-amgen-inc-nasdaqamgn-sabre-corporation-nasdaqsabr/&cid=52779692684562&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNF4ZuQa_9Yxcd-SUbBrRYAlTnwOAw""",52,"""Investing News Update"""
"""Nov 28, 2017""","""Hot Stock to Track: Amgen Inc (NASDAQ:\u00a0AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://alphabetastock.com/hot-stock-to-track-amgen-inc-nasdaq-amgn/&cid=52779693527369&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNH2pz_fdXgO_OHwL7T7NaPsrBlHoQ""",53,"""Alpha Beta Stock"""
"""Nov 28, 2017""","""Investors watching high dividend yield of: Amgen Inc.\u00a0(AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.analystsbuzz.com/2017/11/28/investors-watching-high-dividend-yield-of-amgen-inc-amgn/&cid=52779694761495&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNHuKSLf4qGp7v4z5WJCDBOSTk2elw""",54,"""Voice Of Analysts"""
"""Nov 27, 2017""","""Amgen Inc., (NASDAQ: AMGN), TechnipFMC plc, (NYSE: FTI), Invesco Ltd., (NYSE\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/27/amgen-inc-nasdaq-amgn-technipfmc-plc-nyse-fti-invesco-ltd-nyse-ivz-big-lots-inc-nyse-big-fascinating-stocks/&cid=52779692986011&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNG3OyWm_pbF0gp1bsuU9zfAYea5cw""",Not Reachable,"""Stocks In The News (press release)"""
"""Nov 28, 2017""","""Important Technical Indicators to Consider: Amgen Inc. (NASDAQ:\u00a0AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.hotstockspoint.com/2017/11/important-technical-indicators-consider-amgen-inc-nasdaq-amgn/&cid=52779690672899&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNE23jY-Aox77NUj24VBggjDAyLbng""",55,"""Hot Stocks Point"""
"""Nov 28, 2017""","""Big Pharma Wins If a Speedy Patent-Challenge Process\u00a0Dies""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.bloomberg.com/gadfly/articles/2017-11-28/inter-partes-review-supreme-court-decision-could-help-big-pharma&cid=52779690552189&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNFgOKGeipN0KhaM1J-Lcg9BerDSvA""",56,"""Bloomberg"""
"""Nov 28, 2017""","""What's Next For Regeneron After A Therapy Trial\u00a0Failure?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.benzinga.com/analyst-ratings/analyst-color/17/11/10840555/whats-next-for-regeneron-after-a-therapy-trial-failure&cid=52779693077347&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNGAYpOEiq2D2t5QIVTbALjtR2iKgQ""",57,"""Benzinga"""
"""Nov 28, 2017""","""Amgen Inc. (AMGN) registers a price change of -0.24% while CorMedix, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stocksgallery.com/2017/11/28/amgen-inc-amgn-registers-a-price-change-of-0-24-while-cormedix-inc-crmd-finishes-with-a-flow-of-1-92/&cid=0&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNF4Qp8sMUpLQOBP9gARReCrjzf14w""",58,"""Stocks Gallery"""
"""15 hours ago""","""Slow recovery in Puerto Rico threatens an important\u00a0industry""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.eenews.net/stories/1060067531&cid=52779695756776&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNFcYPhPh-k8m7HSAVH3eCJ9pzHTgw""",59,"""E&E News"""
"""Nov 28, 2017""","""Describing Technical Facts through Ratio Views: Amgen Inc. (NASDAQ:AMGN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.investingbizz.com/2017/11/describing-technical-facts-through-ratio-views-amgen-inc-nasdaqamgn-akorn-inc-nasdaqakrx/&cid=52779695735282&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNGNFOdv8qE3kZgHs8CQl3WJOaZ0zQ""",60,"""Investing News Update"""
"""13 hours ago""","""iShares Russell 1000 Value ETF Experiences Big\u00a0Inflow""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/ishares-russell-1000-value-etf-experiences-big-inflow1-cm884055&cid=52779696547298&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNE9CQhr4xxTIRWcQrDcQ984p1v5Fg""",61,"""Nasdaq"""
"""Nov 26, 2017""","""Is Amgen Inc. (NasdaqGS:AMGN) Providing Enough Return For\u00a0Investors?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://mtnvnews.com/is-amgen-inc-nasdaqgsamgn-providing-enough-return-for-investors/356137/&cid=52779694751574&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNEEVlHswJkP9qHnTN1WcrPy16p_bg""",62,"""MTNV"""
"""10 hours ago""","""Analysts' Recommendation in Spotlight: Amgen Inc. (NASDAQ:\u00a0AMGN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.wallstreetnews24.com/2017/11/29/analysts-recommendation-in-spotlight-amgen-inc-nasdaq-amgn-2/&cid=52779696555537&ei=mqAfWoHEE4n9jAHGyL64Cg&usg=AFQjCNEVPIXHd47pv_Sy9V99umBrW3GC-A""",63,"""The Investor Guide"""
"""Nov 17, 2017""","""Amgen launches Enbrel Mini with Autotouch in\u00a0U.S.""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3716438&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNGAX7p8FZaLJ532AkQpdU_lOcKbaQ""",Not Reachable,"""Reuters Key Development"""
"""Nov 14, 2017""","""Temasek Holdings takes share stake in Vantiv Inc, raises share stake in\u00a0Amgen""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3713124&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNEOMhwyU_De4l1vYeWO5EmqmXCOUA""",Not Reachable,"""Reuters Key Development"""
"""Nov 10, 2017""","""Amgen receives positive CHMP opinion to expand use of Nplate in pediatric patients with chronic immune thrombocytopenic\u00a0purpura""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3710308&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNEa0zvLf-pk7PirQj8btV-8r1qUWQ""",Not Reachable,"""Reuters Key Development"""
"""Nov 2, 2017""","""Amgen, Novartis announce expanded collaboration with Banner Alzheimer's\u00a0Institute""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3702884&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNEMj_2NPxf4A6UFLI-Qpdke-wathg""",Not Reachable,"""Reuters Key Development"""
"""Oct 30, 2017""","""Kymera Therapeutics announces $30 mln series A financing\u00a0round""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3698490&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNEBWFE8kwDit8QszUWXszjQ5Kk4Ew""",Not Reachable,"""Reuters Key Development"""
"""Oct 25, 2017""","""Amgen reports Q3 non-GAAP earnings per share of\u00a0$3.27""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3694532&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNEZIZhSVRA3yalNkZl11s4wLvrmJQ""",Not Reachable,"""Reuters Key Development"""
"""Oct 23, 2017""","""Amgen's Phase 3 A.R.R.O.W. study of once-weekly KYPROLIS regimen meets primary\u00a0endpoint""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3692150&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNFZI6h7f57d9F8Hu9aMTaMQmhlWgw""",Not Reachable,"""Reuters Key Development"""
"""Oct 16, 2017""","""Amgen and Boston Children's Hospital enter into neuroscience research\u00a0collaboration""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3688170&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNF1YCkiOeUAT5Xc3Q8YAgskAX4LNA""",Not Reachable,"""Reuters Key Development"""
"""Oct 5, 2017""","""U.S. Appellate Court rules Sanofi, Regeneron can continue manufacturing PRALUENT in\u00a0U.S.""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3682861&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNEtU1nX72JwTXpeGfw__uhW3o7GGg""",Not Reachable,"""Reuters Key Development"""
"""Oct 3, 2017""","""Amgen, CytomX therapeutics announce strategic collaboration in\u00a0Immuno-Oncology""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3682060&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNGvcYbiEANVq_8bcKjkd6Ytz6XGyQ""",Not Reachable,"""Reuters Key Development"""
"""Sep 28, 2017""","""Amgen and AbbVie agree to settlement allowing commercialization of\u00a0Amgevita""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3679468&ei=GaEfWtmvLNTa2AaJ143ABw&usg=AFQjCNGjXRGthmdWIYeMDvDaJuMFjUwXog""",Not Reachable,"""Reuters Key Development"""
"""Sep 26, 2017""","""Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in\u00a0China""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3678101&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFNMIEK9EwHQDCMdb-S1QsjT3AnRA""",Not Reachable,"""Reuters Key Development"""
"""Sep 25, 2017""","""Amgen provides update on Hurricane\u00a0Maria""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3677222&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEDfN0zLHfbwQA1n9Q8T1xrOvpCLg""",Not Reachable,"""Reuters Key Development"""
"""Sep 19, 2017""","""Cytokinetics announces dosing of first patient in Japan in phase 3 clinical trial of omecamtiv mecarbil in patients with heart\u00a0failure""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3674478&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNHg5sr76R2stryCkVxc1Jmp3IU18g""",Not Reachable,"""Reuters Key Development"""
"""Sep 11, 2017""","""Adello Biologics says FDA accepts for review co's Biologics License Application for proposed filgrastim\u00a0biosimilar""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3670465&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEP8IFo7Wrp2hhu7lHpc-Gm-mJfXg""",Not Reachable,"""Reuters Key Development"""
"""Aug 31, 2017""","""European Commission approves expanded use of Mimpara for the treatment of secondary hyperparathyroidism in children with end-stage renal disease on\u00a0dialysis""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3665758&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFKtdzvZZX6JPpzLqKQqnRtS0Jr4w""",Not Reachable,"""Reuters Key Development"""
"""Aug 30, 2017""","""FDA accepts Amgen's filing of a supplemental new drug application to add overall survival results to Kyprolis\u00ef\u00bf\u00bd (carfilzomib)\u00a0label""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3664596&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEnsrilUocV9hMLmsO1bZlQ596eOg""",Not Reachable,"""Reuters Key Development"""
"""Aug 14, 2017""","""Temasek Holdings takes stake in JPMorgan, Biogen,\u00a0Celgene""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3652471&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEt2Yigo-YjXWnNn498HfWKftBqSA""",Not Reachable,"""Reuters Key Development"""
"""Jul 31, 2017""","""Amgen submits supplemental biologics license application for Prolia in glucocorticoid-induced\u00a0osteoporosis""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3639961&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNGSBg_UqDxDqY1nssNWg2HRFjp2ig""",Not Reachable,"""Reuters Key Development"""
"""Jul 31, 2017""","""Amgen and Allergan submit biosimilar Biologics License application for ABP 980 to U.S.\u00a0FDA""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3639965&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFbj_xZKIeUPWi4g36I5pyTawrYmw""",Not Reachable,"""Reuters Key Development"""
"""Jul 28, 2017""","""Amgen sets quarterly dividend of\u00a0$1.15/shr""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3638972&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNHgPDHd6GHItvi9cDImkt_kASkf0Q""",Not Reachable,"""Reuters Key Development"""
"""Jul 27, 2017""","""FDA grants priority review for Amgen's supplemental biologics license application for\u00a0Repatha""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3638027&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNGDN7EcneeCvrcMJWLVGXZSijhysg""",Not Reachable,"""Reuters Key Development"""
"""Jul 25, 2017""","""Amgen Q2 GAAP shr\u00a0$2.91""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3635294&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNGb77decs_LKET5CFTU2rmKsfwfJA""",Not Reachable,"""Reuters Key Development"""
"""Jul 25, 2017""","""Amgen Q2 GAAP shr\u00a0$2.91""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3635228&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEDR-yB4x4GVBapwka2VoQG3Q_GpA""",Not Reachable,"""Reuters Key Development"""
"""Jul 20, 2017""","""Amgen says FDA accepts biologics license application for\u00a0Aimovig""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3632713&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFb96skNVff6KeBzq5eHBBIhTpilg""",Not Reachable,"""Reuters Key Development"""
"""Jul 18, 2017""","""Amgen and Array BioPharma announce preclinical license and collaboration\u00a0agreement""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3630770&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNGqX565xCX_UiHRQME3vRiQ4lhHBg""",Not Reachable,"""Reuters Key Development"""
"""Jul 14, 2017""","""Amgen submits regulatory applications in US,\u00a0Europe""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3629001&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNHJiNeJkH6z0uqn4UNEoVya-cXsmw""",Not Reachable,"""Reuters Key Development"""
"""Jul 13, 2017""","""Amgen, Allergan to discuss data supporting biologics license application for ABP\u00a0215""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3627971&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEv3vFmzl6p26QdxiqhBhKLgaNZMQ""",Not Reachable,"""Reuters Key Development"""
"""Jul 11, 2017""","""Amgen says FDA grants full approval for Blincyto to treat relapsed or refractory b-cell precursor acute lymphoblastic\u00a0leukemia""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3626546&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFmMOL3UnJtjdoPY-5_h08NYzqQsg""",Not Reachable,"""Reuters Key Development"""
"""Jun 29, 2017""","""FDA approves Vectibix for use in wild-type RAS metastatic colorectal\u00a0cancer""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3620453&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNHUjvJ5-ox1LoFFhAnRF6yjn7dvWw""",Not Reachable,"""Reuters Key Development"""
"""Jun 23, 2017""","""Amgen receives positive CHMP opinion to expand use of\u00a0mimpara""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3617265&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEK5D7GJILvjsdQ5Cb2JXtY01BIzw""",Not Reachable,"""Reuters Key Development"""
"""Jun 12, 2017""","""Coherus to take nearly 6 months to respond to FDA's requests on Neulasta\u00a0biosmilar""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3610436&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEfYTKOuVeGY7kv3uD56P2EkBbrHA""",Not Reachable,"""Reuters Key Development"""
"""May 18, 2017""","""Amgen submits Biologics License Application to the FDA for\u00a0erenumab""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3596917&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEyFQgO-tZ-1NTwOUm-iXZyHymGxQ""",Not Reachable,"""Reuters Key Development"""
"""Apr 24, 2017""","""Amgen announces expanded commercial collaboration with Novartis for erenumab in\u00a0migraine""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3574054&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFtZk4F1caP7l-CGAZj6TCImVyKpw""",Not Reachable,"""Reuters Key Development"""
"""Apr 4, 2017""","""Amgen submits applications in the U.S. and Europe to expand current indication for\u00a0xgeva""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3562291&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNF6nCXEJfNzJ70RPJ7U623GmSYawg""",Not Reachable,"""Reuters Key Development"""
"""Mar 29, 2017""","""FDA grants priority review for Amgen's Blincyto supplemental biologics license\u00a0application""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3558238&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNGcnAoA_6_5WRyQoKiltZ7p3Y7cEA""",Not Reachable,"""Reuters Key Development"""
"""Mar 23, 2017""","""European Commission approves Amgevita for treatment of certain inflammatory\u00a0diseases""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3554191&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEo282D-KNVjbQUC_fryH-JxF1i6A""",Not Reachable,"""Reuters Key Development"""
"""Mar 14, 2017""","""Amgen Inc reports four-year follow-up results from Repatha Osler-1\u00a0study""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3547327&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFeK-3xn31OcnkTQBtUNtUloyKu2g""",Not Reachable,"""Reuters Key Development"""
"""Mar 13, 2017""","""Repatha demonstrates reduced need for apheresis in patients with high LDL\u00a0cholesterol""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3545738&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNE8VwHaXi59pVhLCnTinL6R89Q-Gw""",Not Reachable,"""Reuters Key Development"""
"""Mar 7, 2017""","""Amgen sets quarterly dividend of $1.15 per\u00a0share""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3542437&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFUrsr5nSe47ZidqIEy1vo9uQAsAw""",Not Reachable,"""Reuters Key Development"""
"""Mar 6, 2017""","""Coherus Biosciences says Amgen files trade secret action against\u00a0company""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3541299&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNHyrEiQXTBhQCRW3ITmDPMtio_xuA""",Not Reachable,"""Reuters Key Development"""
"""Feb 28, 2017""","""Amgen announces positive results from planned overall survival analysis of phase 3 head-to-head ENDEAVOR\u00a0trial""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3538139&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNEtpDmUzi4PDO1acGeNfqcwPsBSBQ""",Not Reachable,"""Reuters Key Development"""
"""Feb 16, 2017""","""Astrazeneca says will get $130 mln as milestone payment after Brodalumab\u00a0approval""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3529442&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFCbMW_P9vpoYTB9qIJWo-vGbaC6g""",Not Reachable,"""Reuters Key Development"""
"""Feb 15, 2017""","""Amgen Inc files for potential mixed shelf size not\u00a0disclosed""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3527819&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNECXKrfpmVS1cmXhqBVJ9D2RyOIUw""",Not Reachable,"""Reuters Key Development"""
"""Feb 14, 2017""","""Amgen Inc files for potential mixed shelf size not disclosed\u00a0<AMGN.O>""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3527820&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNGGhqcl7-TJgDt2YfJaVny9WB4IxQ""",Not Reachable,"""Reuters Key Development"""
"""Feb 14, 2017""","""Amgen submits supplemental biologics license application for\u00a0BLINCYTO""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3527426&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFCLFIbWtvWp5BuatVB-u8oYJkInQ""",Not Reachable,"""Reuters Key Development"""
"""Feb 8, 2017""","""Regeneron pharmaceuticals says appeals court grants stay of permanent injunction for\u00a0praluent""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3523224&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNHfg2vSohl8eiGemifjtiY3ubTEPg""",Not Reachable,"""Reuters Key Development"""
"""Feb 7, 2017""","""FDA approves Amgen's Parsabiv, first new treatment in more than a decade for secondary hyperparathyroidism in adult patients on\u00a0hemodialysis""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3522263&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFmUwFsWv6AVEjQCIqxxx2wVxV0-g""",Not Reachable,"""Reuters Key Development"""
"""Feb 2, 2017""","""Amgen CEO expects to see U.S. tax\u00a0reform""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3519986&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNGQRx0MHGtP9TBf-xoqD1BOAh51xw""",Not Reachable,"""Reuters Key Development"""
"""Feb 2, 2017""","""Amgen reports Q4 EPS\u00a0$2.59""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3519913&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNHcrxQ0ZcmAqlZ9r5OpTy6Paz832A""",Not Reachable,"""Reuters Key Development"""
"""Feb 2, 2017""","""Cytokinetics and Royalty Pharma announce $100 million transaction for Omecamtiv\u00a0Mecarbil""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3519667&ei=rKEfWtG7G4GG2Ab8_LzoDA&usg=AFQjCNFGjpiyYdRAdxzSv0CdSL19vWc9YQ""",Not Reachable,"""Reuters Key Development"""
"""Jan 10, 2017""","""Amgen comments on Delaware court's ruling on PCSK9 patent\u00a0litigation""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3506102&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNEq2ecE7c8JO278YChA42WGNwLO_A""",Not Reachable,"""Reuters Key Development"""
"""Jan 9, 2017""","""Amgen comments on Delaware court's ruling on PCSK9 patent\u00a0litigation<AMGN.O><REGN.O><SASY.PA>""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3506104&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNHslicBmwppjauLSfwe9wmmChPiLw""",Not Reachable,"""Reuters Key Development"""
"""Jan 9, 2017""","""Amgen and Davita enter into new sourcing and supply\u00a0agreement""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3505696&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNFMnvG0kU-biDnmFJ7BHJr1VVT1dg""",Not Reachable,"""Reuters Key Development"""
"""Jan 6, 2017""","""Court grants permanent injunction for infringement of Amgen's Repatha\u00a0patents""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3504779&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNFPzxPGGzleFfnwAxm8E68FIJHsoQ""",Not Reachable,"""Reuters Key Development"""
"""Dec 20, 2016""","""Amgen announces 15 pct increase in Q1 2017\u00a0dividend""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3498406&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNFkdGCn2lXoBnbAuNWAdutKacHtIA""",Not Reachable,"""Reuters Key Development"""
"""Dec 20, 2016""","""Amgen Astellas and Astellas announce submission of application for investigational osteoporosis medication romosozumab in\u00a0Japan""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3497817&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNFqePoYEph7XKmxRJVLDDnUFwHYDw""",Not Reachable,"""Reuters Key Development"""
"""Dec 20, 2016""","""UCB and Amgen seek marketing approval of romosozumab in\u00a0Japan""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3497858&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGMX45uvCbkndGzO0te8WDjcLIL0A""",Not Reachable,"""Reuters Key Development"""
"""Dec 2, 2016""","""Amgen and Allergan submit biosimilar marketing\u00a0authorization""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3489271&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGGH2iapJVwvvOKFhrR0u0sZib46g""",Not Reachable,"""Reuters Key Development"""
"""Dec 1, 2016""","""Cytokinetics starts phase 3 clinical trial of omecamtiv\u00a0mecarbil""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3488300&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNEPga0AUcoZzIeIU6kewJEIeYy11g""",Not Reachable,"""Reuters Key Development"""
"""Nov 15, 2016""","""Amgen, Allergan submit biosimilar biologics license application for ABP 215 to U.S.\u00a0FDA""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3479331&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGbLXTTROLW7Dyq6xI6Uf8tziLKYg""",Not Reachable,"""Reuters Key Development"""
"""Nov 10, 2016""","""Janssen reports clinical trial collaboration and supply agreement with Amgen to evaluate Daratumumab in combination with\u00a0Carfilzomib""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3475068&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGOOxFs0HQ2x0ZG1SnYc5xDR3-60g""",Not Reachable,"""Reuters Key Development"""
"""Nov 4, 2016""","""FDA approves expanded use of ENBREL to treat children with chronic moderate-to-severe plaque\u00a0psoriasis""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3470498&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGp__t77pYq2tP8tz1avxeh8-UO4A""",Not Reachable,"""Reuters Key Development"""
"""Oct 28, 2016""","""Arrowhead Pharma files for sale of aggregate of 3 mln shares of co's common stock by selling shareholder\u00a0Amgen""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3464991&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNFMvXuCmQ-GQvRFpg0JZHNHwhdERQ""",Not Reachable,"""Reuters Key Development"""
"""Oct 27, 2016""","""Amgen unlikely to launch Humira biosimilar in\u00a02017""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3463661&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGjHvpokvPWpnBD69FjrJL4in4HnA""",Not Reachable,"""Reuters Key Development"""
"""Oct 27, 2016""","""Amgen Inc Q3 Non-GAAP EPS\u00a0$3.02""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3463559&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNECP4iJBMrnia01K4xqQZsgZ2e_FQ""",Not Reachable,"""Reuters Key Development"""
"""Oct 25, 2016""","""Amgen to invest in israel-based ehealth\u00a0ventures""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3460219&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNFjzY6ss-RX10qUaHygdF7kRR_oPg""",Not Reachable,"""Reuters Key Development"""
"""Oct 24, 2016""","""Unilife Corp implemented cost reduction\u00a0measures""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3459328&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNEvV4WEx63UzOVWYBGraWJljx18Aw""",Not Reachable,"""Reuters Key Development"""
"""Oct 20, 2016""","""Amgen announces positive top-line results from Xgeva (Denosumab) Phase 3\u00a0trial""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3457751&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNFDQcJJ1a9ivwjRI7OLmRWleAZq6Q""",Not Reachable,"""Reuters Key Development"""
"""Oct 14, 2016""","""Amgen announces appointment of Ellen Kullman to\u00a0board""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3454255&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNHlQRFHmiJhyDeN1EVgaBgPSVvPAg""",Not Reachable,"""Reuters Key Development"""
"""Oct 4, 2016""","""Nuevolution: strategic collaboration with Amgen in oncology and\u00a0neuroscience""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3448936&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGZ_E44TgmZ2mq17tgPL4jt_Dne9g""",Not Reachable,"""Reuters Key Development"""
"""Sep 26, 2016""","""Amgen and UCB say FDA accepts biologics license application for\u00a0romosozumab""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3445343&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGuHNuNS-8JHJTzeiHGm71OQbE9gw""",Not Reachable,"""Reuters Key Development"""
"""Sep 23, 2016""","""FDA approves Amgen's Amjevita\u00a0(Adalimumab-Atto)""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3444775&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGG4jUM_PlwBId6rxbhf5LjOjgK8Q""",Not Reachable,"""Reuters Key Development"""
"""Sep 23, 2016""","""U.S. FDA approves Amjevita, a biosimilar to\u00a0Humira""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3444763&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNHN4427iC-ps8-ZRjKlq-TkSrs3sQ""",Not Reachable,"""Reuters Key Development"""
"""Sep 20, 2016""","""Amgen announces positive top line results from Phase 3 GLAGOV imaging study of\u00a0Repatha(evolocumab)""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3443035&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNHxakdrhv28Bu1JNcpU_c54-NkPpA""",Not Reachable,"""Reuters Key Development"""
"""Sep 16, 2016""","""Dr.Reddy's Labs expands collaboration with Amgen in\u00a0India<AMGN.O><REDY.NS>""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3441851&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNHeWix8Musk93iAg-MjPjW88XuLag""",Not Reachable,"""Reuters Key Development"""
"""Sep 15, 2016""","""Amgen presents positive data at EHMTIC 2016, Erenumab reduces\u00a0migraine""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3441564&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGkjJYnpAvHrQYNYDX5CSdkcQalsg""",Not Reachable,"""Reuters Key Development"""
"""Sep 9, 2016""","""Apobiologix comments on patent infringement litigation about Grastofil,\u00a0Lapelga""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3439482&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNHCJTC1aEHCYLzQXkg87hM3efw5CA""",Not Reachable,"""Reuters Key Development"""
"""Sep 1, 2016""","""Amgen gets commercial rights from Boehringer\u00a0Ingelheim""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3436255&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNEyE8GtpNNLC1FFKl0aplQycgcRZA""",Not Reachable,"""Reuters Key Development"""
"""Sep 1, 2016""","""Cytokinetics and Amgen to advance Omecamtiv Mecarbil to phase\u00a03""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3436231&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNElCjLzaORcqNCzRIS7Us4GhkimBA""",Not Reachable,"""Reuters Key Development"""
"""Sep 1, 2016""","""Amgen and servier extend omecamtiv mecarbil\u00a0collaboration""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3436239&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGS3RURadIb4qsAe96DTmAVppXSCQ""",Not Reachable,"""Reuters Key Development"""
"""Aug 30, 2016""","""U.S. FDA approves Erelzi, a biosimilar to\u00a0Enbrel""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3434926&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNEte9j9yHWJmR_kvB-Kp55uYZhohQ""",Not Reachable,"""Reuters Key Development"""
"""Aug 24, 2016""","""Amgen says FDA issues complete response letter for NDA for\u00a0Parsabiv""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3431769&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNFZkl-kUr1TND6F3PQrEi3QAUdnYw""",Not Reachable,"""Reuters Key Development"""
"""Aug 10, 2016""","""Amgen files for potential senior notes offerings, size not\u00a0disclosed""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3423361&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNEUaXXzzQuEdE42naFjepz6p_BvlQ""",Not Reachable,"""Reuters Key Development"""
"""Aug 2, 2016""","""Amgen reports 8.9 pct passive stake in Advaxis as of Aug\u00a01""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3417234&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNEw4bEn52VXBpf0CVvzRCPqFeTx1w""",Not Reachable,"""Reuters Key Development"""
"""Jul 27, 2016""","""Amgen reports second quarter 2016 financial\u00a0results""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3412936&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGAWO3N1GuhAjmWQ7PADy5KkZ9q-w""",Not Reachable,"""Reuters Key Development"""
"""Jul 22, 2016""","""Amgen declares quarterly dividend of $1 per\u00a0share""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3410197&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNGShv9KtpYB5dhGsxoDsY-J9r3y7A""",Not Reachable,"""Reuters Key Development"""
"""Jul 22, 2016""","""Amgen and UCB submit biologics license application for romosozumab to the\u00a0FDA""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3409633&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNF4JiNR-BTXXU1El2Xsf2T4eWZRWw""",Not Reachable,"""Reuters Key Development"""
"""Jul 21, 2016""","""Amgen announces settlement of securities\u00a0litigation""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3408677&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNH8LdIvCmDiLo3nIKdbqag34Rgnig""",Not Reachable,"""Reuters Key Development"""
"""Jul 14, 2016""","""Amgen and Daiichi Sankyo agree to commercialize Biosimilars in\u00a0Japan""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3404633&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNE5TLbmTK2VevPm32F97K7yyCK-hA""",Not Reachable,"""Reuters Key Development"""
"""Jul 12, 2016""","""Amgen to discuss data supporting biologics license application for ABP\u00a0501""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3403775&ei=r6EfWtHiDofSjAHDvqqQDA&usg=AFQjCNHKCFLJcTQZv2JiyB_yUQtr1P825g""",Not Reachable,"""Reuters Key Development"""
"""Jun 13, 2016""","""Amgen announces FDA advisory committee meeting to review ABP\u00a0501""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3390397&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNE9cc_17hwxFpKaDbidah839zHQKA""",Not Reachable,"""Reuters Key Development"""
"""Jun 10, 2016""","""Amgen says interim phase 3 shows Blincyto improved overall survival in\u00a0patients""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3389532&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNFvLPRhB3QXtHRIZIHRewy7d0-FAg""",Not Reachable,"""Reuters Key Development"""
"""May 27, 2016""","""Amgen receives positive CHMP opinion to extend indication of\u00a0Kyprolis""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3383001&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNFcdRN71GNSmGLhal0TRgx_4du3dg""",Not Reachable,"""Reuters Key Development"""
"""Apr 28, 2016""","""Amgen Inc raises FY 2016\u00a0guidance""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3365734&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNG2G-wkRSojcnWXxtKSuhZe3R_QlQ""",Not Reachable,"""Reuters Key Development"""
"""Mar 2, 2016""","""Amgen Inc announces 2016 second quarter\u00a0dividend""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3337851&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNGTtlNrvLf9woSHXf82u13CyiXVSg""",Not Reachable,"""Reuters Key Development"""
"""Feb 22, 2016""","""Unilife Corp and Amgen enter strategic collaboration for injectable drug delivery\u00a0systems""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3333762&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNFpFrgd7wtvlfpZu-R6zs-9B1yU0w""",Not Reachable,"""Reuters Key Development"""
"""Feb 22, 2016""","""UCB and Amgen announce positive top-line results from phase 3 study of\u00a0Romosozumab""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3333649&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNEGRQLqqSSHea9xWYORVvb_Hz_-Lg""",Not Reachable,"""Reuters Key Development"""
"""Feb 4, 2016""","""Amgen Inc says Phase 3 study of Blincyto met primary\u00a0endpoint""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3328954&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNEH9CAmTxvoRx87ktN3KWbe4HxV6w""",Not Reachable,"""Reuters Key Development"""
"""Feb 3, 2016""","""Biocartis and Amgen collaborate on rapid RAS biomarker\u00a0testing""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3328094&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNEjLJIYx1_ih-zbTd4OqB-0f5CZCg""",Not Reachable,"""Reuters Key Development"""
"""Jan 28, 2016""","""Amgen Inc raises FY 2016\u00a0guidance""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3325411&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNFq6FJ6Yfr0gZ-0rCZrbpnpvGGczA""",Not Reachable,"""Reuters Key Development"""
"""Jan 21, 2016""","""Amgen Inc says FDA approves new Kyprolis combination therapy for multiple\u00a0myeloma""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3322577&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNGXNNT-fG00_cvR7f51U-59IJpKWQ""",Not Reachable,"""Reuters Key Development"""
"""Dec 15, 2015""","""Amgen Inc announces 27 percent increase in 2016 first quarter\u00a0dividend""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3311349&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNG6O9pUIpBHUeplxea4G3Le8FfL0g""",Not Reachable,"""Reuters Key Development"""
"""Dec 4, 2015""","""Amgen And Merck Announce Cancer Immunotherapy Collaboration For Patients With Non-Hodgkin\u00a0Lymphoma""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F3307407&ei=saEfWsnZBMzRjAHNnI-wDw&usg=AFQjCNGh5wObjx1yFOLTkQ5kHgqYO_XjIQ""",Not Reachable,"""Reuters Key Development"""
